share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Warden Kathy J

默沙東 | 4:持股變動聲明-董事 Warden Kathy J
美股SEC公告 ·  06/04 15:03

Moomoo AI 已提取核心訊息

On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
On May 31, 2024, Kathy J Warden, associated with Northrop Grumman Corp, executed a transaction involving Merck & Co., Inc. (MRK) common stock. Following the transaction, Warden holds a total of 500 shares of Merck & Co. directly. The nature of the transaction and the number of shares involved were not disclosed, but the post-transaction holdings suggest a significant investment in the pharmaceutical company.
2024年5月31日,northrop grumman corp有關人士Kathy J Warden參與了一筆牽涉Merck & Co., Inc.(MRK)普通股的交易。交易後,Warden 直接持有Merck & Co.的500股。本次交易的性質和涉及的股份數量未披露,但交易後的持股顯示出對這家藥品公司的重大投資。
2024年5月31日,northrop grumman corp有關人士Kathy J Warden參與了一筆牽涉Merck & Co., Inc.(MRK)普通股的交易。交易後,Warden 直接持有Merck & Co.的500股。本次交易的性質和涉及的股份數量未披露,但交易後的持股顯示出對這家藥品公司的重大投資。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息